# Baranco

> Baranco is a VC fund backing Medical, Health Care and Neuroscience. See 2 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Apr 2023
- Lead investor: 0%
- Last updated: Sep 2026

Baranco is a VC fund focused on Medical and Health Care. The venture arm of George T Baran (Aerochamber)

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Neuroscience | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xenocor | Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. This technology emerged from the Center for Medical Innovation at the University of Utah. The current product offerings are FDA cleared, CE Marked and patent protected. | $10M | Series A | Apr 18, 2023 | https://xenocor.com/ |
| Sky Medical Technology | Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatoryconditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need. | $13.5M | Series B | Sep 01, 2017 | http://www.skymedtech.com |

2 of 2 investments shown.

## Co-investors
- [Juno Capital Partners](https://shizune.co/investors/profile/juno-capital) — VC Fund, 2 deals together
- [Deepbridge Capital](https://shizune.co/investors/profile/deepbridge-capital) — VC Fund, 1 deal together
- [GenHenn Venture](https://shizune.co/investors/profile/genhenn-venture) — VC Fund, 1 deal together
- [Nissha Co., Ltd.](https://shizune.co/investors/profile/nissha-printing) — VC Fund, 1 deal together
- Patel Family Investment — VC Fund, 1 deal together
- Revera Home Health Business — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Baranco invest in?

Baranco invests primarily in Medical, Health Care and Neuroscience startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Baranco last invest?

The most recent investment recorded for Baranco closed in Apr 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co